|
12 Oct 2021 |
Supernus Pharmaceuticals to Acquire Adamas Pharmaceuticals Strengthening its CNS Product Portfolio
|
|
11 Oct 2021 |
Pacira BioSciences to Acquire Flexion Therapeutics Further Expanding Leadership Position in Non-Opioid Pain Management
|
|
08 Oct 2021 |
Amgen and Neumora Therapeutics Announce Strategic R&D Collaboration to Accelerate Novel Precision Therapies for Brain Diseases
|
|
06 Oct 2021 |
Newly Formed Lanier Biotherapeutics Enters into License Agreement with Alloy Therapeutics
|
|
06 Oct 2021 |
Voyager Therapeutics Announces License Option Agreement with Pfizer for Next-Generation TRACERᵀᴹ AAV Capsids to Enable Neurologic and Cardiovascular Gene Therapy Programs
|
|
05 Oct 2021 |
Exo Therapeutics Raises $78 Million Series B Financing
|
|
05 Oct 2021 |
IpiNovyx Bio Closes $10 Million Seed Financing to Advance Best-in-Class Immunoproteasome Inhibitors Toward First-in-Human Clinical Studies
|
|
04 Oct 2021 |
Selecta Biosciences Announces Strategic Licensing Agreement with Takeda to Develop Next-Generation Gene Therapies for Patients with Lysosomal Storage Disorders
|
|
01 Oct 2021 |
Sumitomo Dainippon Pharma and Otsuka Announce a Worldwide Collaboration and License Agreement for Four Psychiatry and Neurology Compounds
|
|
30 Sep 2021 |
Merck to Acquire Acceleron Pharma Inc.
|
|
30 Sep 2021 |
Expansion Therapeutics Raises $80 Million Series B Financing to Treat Neurodegenerative Diseases
|
|
29 Sep 2021 |
AstraZeneca to fully acquire Caelum Biosciences
|
|
28 Sep 2021 |
Syndax Pharmaceuticals and Incyte Announce Global Collaboration to Develop and Commercialize Axatilimab for Chronic Graft-Versus-Host Disease and Other Fibrotic Diseases
|
|
27 Sep 2021 |
New startup Aglaia Therapeutics raises €4M in seed funding to overcome resistance in oncology targeted therapies
|
|
23 Sep 2021 |
AstraZeneca to discover and develop self-amplifying RNA therapeutics in new collaboration with VaxEquity
|
|
21 Sep 2021 |
Novartis acquires Arctos Medical, expanding optogenetics portfolio to bring gene therapies to patients with severe vision loss
|
|
21 Sep 2021 |
Boehringer Ingelheim Acquires Abexxa Biologics to Further Expand its Research Efforts in Cancer Immunology and Novel Immunotherapeutic Approaches
|
|
21 Sep 2021 |
858 Therapeutics Launches with Proven Team and $60 Million Series A Financing
|
|
21 Sep 2021 |
Gubra ApS and Bayer AG collaborate to develop next generation cardiorenal treatments
|
|
15 Sep 2021 |
AbCellera Announces Collaboration with Moderna to Discover Therapeutic Antibodies for mRNA Medicines
|
|
15 Sep 2021 |
AzurRx BioPharma Announces Acquisition of First Wave Bio and its Proprietary Niclosamide Formulations Targeting Multi-Billion Dollar Inflammatory Bowel Disease Indications
|
|
15 Sep 2021 |
Nuvectis Pharma In-Licenses Exclusive Worldwide Rights to a Novel SRC/YES1 Inhibitor (NXP900) from the University of Edinburgh, Scotland
|
|
14 Sep 2021 |
Vipergen Establishes Research Partnership with PhoreMost Focused on DNA Encoded Library (DEL)-Based Drug Discovery
|
|
14 Sep 2021 |
AbbVie and REGENXBIO Announce Eye Care Collaboration
|
|
11 Sep 2021 |
Flamingo Therapeutics Expands Alliance with Ionis Pharmaceuticals to Develop RNA-targeted Therapies for Oncology
|
